How do Health Savings Account‑style subsidies compare to premium tax credits in protecting people with high medical costs?

Checked on January 2, 2026
Disclaimer: Factually can make mistakes. Please verify important information or breaking news. Learn more.

Executive summary

Health Savings Account–style subsidies (HSA subsidies) primarily lower taxes on out‑of‑pocket medical spending and pair with high‑deductible plans that have lower premiums, while premium tax credits (PTCs) lower monthly premiums directly and expand access to comprehensive coverage; the evidence and the recent policy debate show PTCs do more to protect people with high medical costs from financial ruin, whereas HSAs disproportionately benefit higher‑income, healthier savers and do little to shield low‑income, high‑need patients [1] [2] [3].

1. How the two mechanisms work and what changed for 2026

Premium tax credits are direct federal subsidies that reduce the monthly premium an enrollee pays for Marketplace plans and were recently enhanced during the pandemic era; those enhancements are scheduled to expire at the end of 2025 unless Congress acts, which would substantially raise enrollees’ net premiums in 2026 [2] [4]. HSAs are individually owned, tax‑advantaged accounts that let people set aside pretax dollars to pay qualified medical expenses, and a 2025 legislative change made all Bronze and Catastrophic Marketplace plans HSA‑eligible for 2026 — a policy that makes low‑premium, high‑deductible plans usable with HSAs but does not let HSA funds pay premiums directly [3] [5].

2. Who gains protection from high medical costs under premium tax credits

PTCs reduce the barrier to comprehensive coverage by lowering or eliminating the monthly premium for people with modest incomes, meaning people with chronic or catastrophic needs remain on plans that cover costs and limit out‑of‑pocket exposure; analyses project that eliminating enhanced PTCs would more than double average net premium payments and drive millions from Marketplace coverage, worsening affordability for people who face large medical bills [2] [6] [7]. Because PTCs are tied to plan benchmark premiums and income, they provide immediate, predictable protection against premium shocks that would otherwise leave high‑cost patients either uninsured or forced into skimpier plans [8] [9].

3. How HSAs perform for people with high medical costs

HSAs are triple tax‑advantaged for savers but, in practice, help those who can contribute substantial sums and who are in higher tax brackets; research summarized by the Center on Budget and Policy Priorities finds HSAs do not reduce overall health spending and instead largely shield spending from taxes, meaning they do little to protect low‑income people who cannot afford large HSA balances and face high deductibles in HSA‑compatible Bronze plans [1]. Crucially, HSA funds generally cannot be used to pay premiums, so they cannot substitute for the immediate subsidy of a premium tax credit that keeps someone in a comprehensive plan when premiums rise [3] [1].

4. Trade‑offs: premiums, deductibles, and risk pooling

Making Bronze and Catastrophic plans HSA‑eligible boosts choices for consumers seeking low monthly premiums, but those plans carry high cost‑sharing that shifts risk to enrollees — a poor match for people with high expected medical spending who need generous coverage rather than tax‑favored savings vehicles [3] [5]. By contrast, PTCs maintain broader risk pooling and affordability; analyses warn that rollback of enhanced PTCs will both raise premiums and concentrate sicker individuals in the Marketplace, raising premiums further — a systemic protection PTCs provide that HSAs cannot replicate [8] [10].

5. Political and practical realities shaping protection for high‑need patients

Some Republican proposals would swap enhanced PTCs for fixed HSA payments or expand HSA eligibility, arguing consumer incentives will lower costs, but watchdogs and policy analysts say those moves would primarily benefit wealthier Americans and leave low‑ and moderate‑income, high‑need patients exposed to large out‑of‑pocket costs or without comprehensive coverage [11] [1]. With enhanced PTCs expiring absent congressional action, policymakers face a clear trade‑off: extend credits to preserve broad protection for people with high medical costs, or pivot toward HSAs that lower tax burdens for savers but do not replicate the targeted, immediate financial protection that tax credits deliver [7] [2].

Want to dive deeper?
How would eliminating enhanced premium tax credits affect uninsured and underinsured rates in each state in 2026?
What evidence exists on HSA account balances and who can realistically use HSAs to cover high deductibles?
How have insurer premiums and marketplace risk pools changed in states that expanded HSA‑eligible plans before 2026?